SCHEMBL9229524

SCHEMBL9229524

CN1CN(CCCCCC=O)c2c1c(=O)[nH]c(=O)n2C

nearest known ligand 0.33

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ MAPK10 P53779 1/20 0.33
▸ EPHX2 P34913 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ TSHR P16473 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8952197 0.88 HSD17B10 (0.34) MAPK10EPHX2MEN1KMT2AHTT
SCHEMBL7201249 0.88 HSD17B10 (0.34) MAPK10EPHX2MEN1KMT2AHTT
SCHEMBL8952275 0.88 HSD17B10 (0.34) MAPK10EPHX2MEN1KMT2AHTT
SCHEMBL8802655 0.88 HSD17B10 (0.34) MAPK10EPHX2MEN1KMT2AHTT
SCHEMBL8952345 0.88 HSD17B10 (0.34) MAPK10EPHX2MEN1KMT2AHTT
SCHEMBL8952266 0.88 HSD17B10 (0.34) MAPK10EPHX2MEN1KMT2AHTT
SCHEMBL9118291 0.88 HSD17B10 (0.34) MAPK10EPHX2MEN1KMT2AHTT
SCHEMBL9027308 0.88 HSD17B10 (0.34) MAPK10EPHX2MEN1KMT2AHTT
SCHEMBL8803812 0.87 HSD17B10 (0.34) MAPK10EPHX2MEN1KMT2AHTT
SCHEMBL8803670 0.86 TK1 (0.43) MAPK10MEN1KMT2ATSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0623133-A4 SUBSTITUTED AMINO ALKYL COMPOUNDS. CELL THERAPEUTICS INC (US) 1995-10-11 — — EP disclosed
EP-0623133-A1 SUBSTITUTED AMINO ALKYL COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-11-09 — — EP disclosed
WO-1994011370-A1 SUBSTITUTED AMINO ALKYL COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-05-26 — — WO disclosed
Send feedback